Zimbabwe has declined a significant US health deal worth 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive information.
This rejection became public following a official document from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official representative later explained that the United States was seeking health data for scientific study and profit while was not willing to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged further negotiations to reach a agreement agreeable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court blocked a related deal with the US after concerns were filed about the security of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.
As per statements, Sixteen nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of bilateral deals were upending frameworks previously established via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future co-operation could be structured in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
Medical experts expressed it acknowledged the government's concerns, but recommended that talks should continue considering much of the nation's HIV programmes depended on foreign aid.
"If technical issues exist, such as those relating to data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.
The situation emphasises the continuing debate between receiving crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.